Leidos (LDOS) Is Considered a Good Investment by Brokers: Is That True?

Leidos (LDOS) holds an Average Brokerage Recommendation (ABR) of 1.69, approximating a Strong Buy to Buy consensus from 16 firms, with 10 Strong Buy ratings. However, the article cautions against relying solely on ABRs due to inherent positive bias from brokerage firms, advocating for the Zacks Rank, based on earnings estimate revisions, as a more reliable indicator. For LDOS, a 0.3% increase in the current year's Zacks Consensus Estimate to $11.22 over the past month has resulted in a Zacks Rank #2 (Buy), suggesting that the stock's positive ABR, when validated by strong earnings estimate revisions, indicates potential for near-term appreciation.

Analysis

Leidos (LDOS) demonstrates a strong bullish consensus from sell-side analysts, reflected in its Average Brokerage Recommendation (ABR) of 1.69 on a 1-to-5 scale. This rating is derived from 16 brokerage firms, of which 10 have issued a "Strong Buy" and one has issued a "Buy," accounting for 62.5% and 6.3% of all recommendations, respectively. This sentiment is further substantiated by fundamental earnings momentum. The Zacks Consensus Estimate for the current year's earnings per share has increased by 0.3% over the past month to $11.22. This positive revision, indicating growing analyst optimism about the company's earnings prospects, has contributed to the stock receiving a Zacks Rank #2 (Buy). The convergence of a strong, broad-based analyst recommendation and a quantifiable upward trend in earnings estimates provides a coherent basis for a positive near-term outlook on the stock.

Key Decisions for Investors

• Investors can interpret the combination of a strong ABR of 1.69 and recent upward earnings estimate revisions as a confirmation of a positive near-term thesis for Leidos.
• The key driver for the bullish rating is the trend in earnings estimates; therefore, monitoring for continued stability or further increases in the $11.22 consensus EPS estimate is critical.
• While the high number of 'Strong Buy' ratings from analysts is notable, portfolio managers should weigh the more dynamic indicator of earnings estimate revisions more heavily when assessing potential for near-term stock price movement.